Small molecule modifiers of the hec1-nek2 interaction in g2/m
AssigneeThe Regents of the University of California
InventorsWen-Hwa Lee, Jiewen Zhu, Chun-Mei Hu
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsWen-Hwa Lee, Jiewen Zhu, Chun-Mei Hu
Estimating the term…
Certain embodiments of the present invention provide selected compounds having a molecular structure according to Formula 1: In Formula 1, Z is —CO—, —SO—, or —SO2—; Ar is phenyl, heteroaryl, or heterocycloalkyl; Het is heteroaryl; R is R″, X, or NR1R2; R′ is R3, or OR3; R″ is R4, or OR4; R1 and R2 are each independently H, alkyl, or acyl; R3 is H, heteroaryl, or alkyl; R4 is H, heteroaryl, or CnH2n+1 (n>2); and X is F, Br, I, CN, or NO2. In some embodiments, compounds having a molecular structure according to Formula 1 have the property of inhibiting a growth of a cell line selected from HeLa and MB468 with a sub-micromolar IC50.
A compound that comprises a molecular structure selected from the group consisting of:
A method, of inhibiting cancer cell growth, comprising exposing cancer cells in a mammal to a cancer growth inhibiting amount of a compound, wherein:
A method, of promoting mitotic catastrophe in cancer cells, comprising exposing cancer cells to a mitotic catastrophe inducing amount of a compound, wherein:
The method of claim 18, wherein the compound comprises the molecular formula:
The method of claim 18, wherein the compound comprises the molecular formula:
The method of claim 18, wherein the compound comprises the molecular formula:
The method of claim 18, wherein the compound comprises the molecular formula:
Dependencies are inferred from the claim text.